Literature DB >> 19248080

Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication.

Amalia Ubeda1, Javier Llopico, M Teresa Sanchez.   

Abstract

BACKGROUND: Raised blood pressure associated with the sodium excipient content of soluble or effervescent analgesic has been previously reported. However, the influence of other anions associated with sodium on blood pressure is still controversial.
METHODS: Observational study of elderly hypertensive patients with uncontrolled blood pressure treated with effervescent paracetamol (3 g/day) for osteoarthritis. Blood pressure was measured before and after (4 weeks or more) switching paracetamol from an effervescent format to a tablet form in 34 patients. Blood pressure was recorded by community pharmacists during a pharmacotherapeutic follow-up service.
RESULTS: Sodium intake in an effervescent form was 74 mmol/day (mainly associated with sodium bicarbonate and carbonate excipients). Initial blood pressure was high (range: 153-168 mmHg systolic and 92-99 mmHg diastolic). Switching to paracetamol tablets (no sodium content) was associated with both lowered systolic pressure of 13.1 mmHg (95%CI: 11.9-14.3, p < 0.0001) and a moderate reduction of diastolic pressure of 2.5 mmHg (95%CI: 2.1-2.9, p < 0.0001). No changes in medication in the study period took place, and weight and lifestyles remained stable. A detailed review of pharmacotherapy and lifestyle reveals no other causes for blood pressure to lower.
CONCLUSIONS: A relationship of causality between the intake of high sodium excipients and high blood pressure in elderly hypertensive individuals, without chloride ions, was found. Clinicians should be aware of possible raised blood pressure when effervescent formulations are prescribed to hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19248080     DOI: 10.1002/pds.1701

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

Review 1.  A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects.

Authors:  Emma J Turtle; James W Dear; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

2.  [Paracetamol for perioperative analgesia. Old substance - new insights].

Authors:  P K Zahn; R Sabatowski; S A Schug; U M Stamer; E M Pogatzki-Zahn
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

Review 3.  Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.

Authors:  Fang Liu; Sejal Ranmal; Hannah K Batchelor; Mine Orlu-Gul; Terry B Ernest; Iwan W Thomas; Talia Flanagan; Catherine Tuleu
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

Review 4.  Cardiovascular risk associated with high sodium-containing drugs: A systematic review.

Authors:  Germain Perrin; Virginie Korb-Savoldelli; Alexandre Karras; Nicolas Danchin; Pierre Durieux; Brigitte Sabatier
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

5.  Changes in prescribing rates of sodium-containing medications in the UK from 2009 to 2018: a cross-sectional study with interrupted time series analysis.

Authors:  Chengsheng Ju; Li Wei; Isla S Mackenzie; Thomas M MacDonald; Jacob George
Journal:  BMJ Open       Date:  2021-02-17       Impact factor: 2.692

Review 6.  Paracetamol: a review with specific focus on the haemodynamic effects of intravenous administration.

Authors:  Elizabeth Chiam; Laurence Weinberg; Rinaldo Bellomo
Journal:  Heart Lung Vessel       Date:  2015

7.  Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study.

Authors:  Jacob George; Waseem Majeed; Isla S Mackenzie; Thomas M Macdonald; Li Wei
Journal:  BMJ       Date:  2013-11-26

8.  Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trial.

Authors:  Mencia Benitez-Camps; Ernest Vinyoles-Bargalló; Oriol Rebagliato-Nadal; Rosa Morros-Pedrós; Helena Pera-Pujadas; Antoni Dalfó-Baqué; Ignacio López-Pavón; Carlos Roca-Sánchez; Rosa Maria Coma-Carbó; Mariano De La Figuera Von Wichmann; Lucas Mengual-Martínez; Carmen Yuste-Marco; Montserrat Teixidó-Colet; Josep M Pepió i Vilaubí; Riera Ciurana-Tost; Rosa Pou-Vila; Ma Antònia Vila-Coll; Josep Maria Bordas-Julve; Rosa Aragonès-Forès; Francisco Javier Pelegrina-Rodríguez; Josep Agudo-Ugena; Carlos Blanco-Mata; Jon de la Iglesia Berrojalbiz; Natalia Burgos-Alonso; Maria Cruz Gómez-Fernández
Journal:  BMC Cardiovasc Disord       Date:  2015-12-10       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.